Stockreport

New Blood Test Predicts Recurrence of Breast Cancer, Months or Even Years Before Relapse [Yahoo! Finance]

Personalis, Inc.  (PSNL) 
Last personalis, inc. earnings: 3/25 04:01 pm Check Earnings Report
PDF The ‘Personalis NeXT Personal® liquid biopsy' test uses whole genome sequencing to identify up to 1,800 mutations in a patient's tumour DNA that can identify recurrence [Read more]